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Compelling evidence suggests that the transcription factor Foxp3 acts as a master switch governing the development
and function of CD4
þ regulatory T cells (Tregs). However, whether transcriptional control of Foxp3 expression itself
contributes to the development of a stable Treg lineage has thus far not been investigated. We here identified an
evolutionarily conserved region within the foxp3 locus upstream of exon-1 possessing transcriptional activity.
Bisulphite sequencing and chromatin immunoprecipitation revealed complete demethylation of CpG motifs as well as
histone modifications within the conserved region in ex vivo isolated Foxp3
þCD25
þCD4
þ Tregs, but not in naı ¨ve
CD25
 CD4
þ T cells. Partial DNA demethylation is already found within developing Foxp3
þ thymocytes; however, Tregs
induced by TGF-b in vitro display only incomplete demethylation despite high Foxp3 expression. In contrast to natural
Tregs, these TGF-b–induced Foxp3
þ Tregs lose both Foxp3 expression and suppressive activity upon restimulation in
the absence of TGF-b. Our data suggest that expression of Foxp3 must be stabilized by epigenetic modification to allow
the development of a permanent suppressor cell lineage, a finding of significant importance for therapeutic
applications involving induction or transfer of Tregs and for the understanding of long-term cell lineage decisions.
Citation: Floess S, Freyer J, Siewert C, Baron U, Olek S, et al. (2007) Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 5(2): e38. doi:10.1371/journal.pbio.
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Introduction
Regulatory T cells (Tregs), which have been shown to play a
pivotal role in the maintenance of self-tolerance within the
immune system, were described originally as CD4
þ T cells
constitutively expressing CD25 [1]. More recently, the fork-
head transcription factor Foxp3 has been shown to be
speciﬁcally expressed in Tregs and to be a central control
element in Treg development and function [2]. Mutation or
deletion of the gene encoding Foxp3 causes severe auto-
immune disease in mice and humans, due to a failure to
generate CD25
þCD4
þ Tregs [3,4], whereas ectopic expression
of Foxp3 in conventional T cells confers suppressive activity
[4,5]. These ﬁndings provided compelling evidence that
Foxp3 acts as a master switch controlling the development
and function of Tregs; however, the molecular mechanisms
leading to its induction remain largely unknown. Recently, an
initial characterization of the human FOXP3 promoter
revealed a basal, T cell–speciﬁc promoter containing several
NF-AT and AP-1 binding sites, which are positively regulating
FOXP3 expression after triggering of the T cell receptor
(TCR) [6].
Occurrence of autoimmunity in thymectomized mice
provided initial evidence that Foxp3
þCD25
þCD4
þ Tregs are
generated as an individual lineage within the thymus [1].
Using mice harboring a GFP-Foxp3 fusion protein-reporter
knockin allele, Fontenot et al. could show that Foxp3
expression becomes prominent in CD4 single-positive (SP)
thymocytes (;83% of Foxp3
gfpþthymocytes) [7,8]. In addition
to the thymic generation of Foxp3
þ Tregs, peripheral
conversion of Foxp3
 CD25
 CD4
þ T cells into Foxp3
þ Tregs
has recently been demonstrated by tolerogenic antigen
application in vivo [9–11] or upon activation in the presence
of TGF-b in vitro [12–17]. To what extent these induced
populations of Tregs acquire a stable phenotype correspond-
ing to that of natural, thymus-derived Tregs is, however,
unclear.
An emerging paradigm in understanding the development
of stable cellular lineages emphasizes the role of epigenetic
mechanisms for the permanent, heritable ﬁxation of distinct
gene expression patterns. Molecular mechanisms of epige-
netic imprinting include selective demethylation of CpG
motifs and histone modiﬁcations as shown for cytokine genes
[18–20]. Whether Treg differentiation also involves elements
of epigenetic regulation has not been studied thus far. We
therefore investigated whether epigenetic alterations such as
DNA methylation and histone modiﬁcations of the foxp3 locus
correlate with Foxp3 expression. The selective association of
chromatin remodeling with a stable Treg phenotype suggests
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Results
CD25
þCD4
þ Tregs Display a Stable Foxp3 Expression
It is assumed that Foxp3
þCD25
þCD4
þ Tregs represent an
individual lineage exhibiting a stable phenotype. To prove
experimentally the stability of Foxp3 expression in natural
Tregs on a cellular level, we adoptively transferred sorted
CD25
þCD4
þ T cells after CFSE (carboxy ﬂuorescein diacetate
succinimide ester) labeling into syngeneic recipients. Four-
teen days after transfer, more than 95% of CFSE
þ cells,
including those that had divided once or twice according to
loss of CFSE, were still Foxp3
þ (Figure 1), supporting data
from a recent publication using a lymphopenic transfer
model [21]. Having shown that Foxp3 is stably expressed in
CD25
þCD4
þ Tregs, we next asked whether epigenetic mod-
iﬁcations of the foxp3 locus might account for the main-
tenance of the long-term identity of Foxp3
þ Tregs.
Epigenetic Modifications of the foxp3 Locus in
Foxp3
þCD25
þCD4
þ Tregs
The lymphoproliferative disorder of scurfy mice is com-
pletely rescued by transgenic complementation with a 30.8-
kilobase (kb) genomic fragment containing the foxp3 gene
from wild-type mice [22]. This indicates that most key
regulatory elements required for proper Foxp3 expression
are located within the transgene including the entire gene, as
well as 12.5 kb and 2.8 kb of 59 and 39 ﬂanking sequences,
respectively. We therefore focused our analysis of epigenetic
modiﬁcations on sequences from the 30.8-kb region and
selected speciﬁc regions for methylation analysis based on
CpG density (Figure 2A): Overlapping amplicons 1 and 2 map
upstream from exon-1, amplicons 3 and 4 align to the seventh
intron. No CpG-rich regions were observed within the Foxp3
promoter located at the putative 59 end of exon-2b, 6.1 kb
upstream from the ﬁrst coding exon [6,22].
We sorted CD25
þCD4
þTregs and conventional CD25
 CD4
þ
T cells from secondary lymphoid organs of male mice. Male
mice were chosen to avoid potential artifacts due to random
X chromosome inactivation since Foxp3 is encoded on the X
chromosome [22]. As expected, the vast majority of sorted
CD25
þCD4
þ Tregs were Foxp3
þ, whereas less than 1% of
CD25
 CD4
þ T cells expressed Foxp3 (Figure 2B).
The methylation status of the foxp3 locus was analyzed by
bisulphite sequencing (see Material and Methods). Interest-
ingly, striking differences between CD25
þCD4
þ Tregs and
conventional CD25
 CD4
þ T cells could be observed. CpG
motifs within amplicons 1 and 2 displayed a high degree of
methylation (;100%) within conventional CD25
 CD4
þ T
cells, but were almost completely demethylated within
CD25
þCD4
þ Tregs (Figure 2C and Table S1). No signiﬁcant
differences were observed for amplicons 3 and 4, showing
that the demethylation process is not a random event, but is
conﬁned to deﬁned regions as was recently found for the
interleukin 2 (IL-2) promoter [23]. Together, our ﬁndings
suggest that demethylation of CpG motifs within selected
elements of the foxp3 locus enable stable Foxp3 expression in
CD25
þCD4
þ Tregs. This view is supported by recent ﬁndings
with human natural killer (NK) cells, which up-regulated
FOXP3 expression in response to IL-2 only after treatment
with the demethylating agent 5-aza-29deoxycytidine, demon-
strating that this gene was constitutively repressed in non-
Tregs by a mechanism involving DNA methylation [24].
Differentially Methylated Element of the foxp3 Locus Is
Evolutionarily Conserved and Possesses Transcriptional
Activity
The differentially methylated element covered by ampli-
cons 1 and 2 is conserved between mice and humans (77.3%
sequence identity). This is not the case for the region covered
by amplicons 3 and 4, which essentially showed no signs of
differential DNA methylation. In silico analysis of the
differentially methylated, conserved region predicts a num-
ber of binding sites for transcription factors, including ATF/
CREB, C/EBPc, Elk-1, Ets-1, Evi-1, Foxp3, GATA-4, NFATc,
NF-jB, SMAD-4, STAT-1, TCF-4, and TTF1 (Figure S1),
indicating that these factors might be involved in the
induction of Foxp3 expression in CD25
þCD4
þ Tregs.
To analyze whether the same region harbors transcrip-
tional activity, we cloned a 1,160–base pair (bp) element
containing the differentially methylated element covered by
amplicons 1 and 2 into the pGL3 luciferase vector in front of
a minimal SV40 promoter. The luciferase vector was trans-
fected into a murine CD4
þ T cell line, and transfected cells
were either left unstimulated or were stimulated with PMA
for 24 h, followed by measurement of luciferase activity. PMA
treatment mimics part of the signals generated after TCR
triggering, which have been shown to be essential for Foxp3
expression [6]. Interestingly, signiﬁcant luciferase activity was
only observed in stimulated cells transfected with the vector
containing the conserved element of the foxp3 locus, but not
in cells transfected with the control vector (Figure 3). Similar
results showing a 5-fold to 7-fold induction of luciferase
activity after stimulation were also obtained with ex vivo
isolated CD25
þCD4
þ Tregs, albeit much lower transfection
Author Summary
Regulatory T cells play a pivotal role in the maintenance of self-
tolerance within the immune system by preventing autoimmunity
or excessive activation of the T cells that respond to pathogens
(naı ¨ve and effector T cells). They differentiate within the thymus, but
can also be de novo induced in the rest of the body. Mechanisms
determining development of a stable regulatory T cell lineage are
unknown. Our study provides evidence for a critical role of
epigenetic modifications in the locus coding for the forkhead
transcription factor Foxp3, which acts as a master switch controlling
regulatory T cell development and function: An evolutionarily
conserved region within the non-coding part of the gene contains
CpG motifs, which are completely demethylated in regulatory T
cells, but methylated in naı ¨ve and effector T cells, whereas we
observed an inverse occurrence of acetylated histones, another
epigenetic chromatin modification. Regulatory T cells induced in
vitro—which, in contrast to natural regulatory T cells, do not display
a stable regulatory T cell phenotype—display only incomplete DNA
demethylation despite high Foxp3 expression. Our data suggest
that expression of Foxp3 must be stabilized by epigenetic
modification to result in a permanent suppressor cell lineage, a
finding of significant importance for therapeutic applications
involving induction or transfer of regulatory T cells and for the
understanding of long-term cell lineage decisions.
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Foxp3 Regulationefﬁciencies were achieved with these primary murine T cells
(unpublished data). Initial experiments targeting the func-
tional activity of selected transcription factors, for which a
binding site in the differentially methylated, conserved
element has been predicted, showed a reduced luciferase
activity if transcription factors of the STAT family were
inhibited by decoy oligonucleotides (unpublished data),
conﬁrming recently published data [24]. Together, our data
assuredly show that the differentially methylated, conserved
element of the foxp3 locus possesses transcriptional activity.
Histone Modifications Indicate Opening of the foxp3
Locus in CD25
þCD4
þ Tregs
DNA demethylation is often linked to acetylation or
methylation of histones, other key features of chromatin
remodeling [25]. To investigate whether this also holds true
for the aforementioned region of the foxp3 locus, we
performed chromatin immunoprecipitation (ChIP) experi-
ments using antibodies speciﬁc for acetylated histone H3,
acetylated histone H4, and trimethylated lysine 4 of histone
H3 (H3K4). Subsequently, the precipitated DNA was used as a
template for amplifying the differentially methylated region
of the foxp3 locus by quantitative real-time PCR. Indeed, in
CD25
þCD4
þ Tregs, the region of interest showed a stronger
association with modiﬁed histones when compared with
conventional CD25
 CD4
þ T cells (Figure 4). Major differ-
ences were observed for the acetylated and trimethylated
histone H3, whereas minor differences were found for the
acetylated histone H4. Together, the ChIP data disclose that
within conventional CD25
 CD4
þ T cells, the foxp3 locus is
packed in a more condensed, inaccessible chromatin struc-
ture, whereas it is located within open euchromatin in
CD25
þCD4
þ Tregs.
Demethylated CpG Motifs in Developing Foxp3
þ
Thymocytes
Having shown that peripheral CD25
þCD4
þ Tregs display a
characteristic methylation status of the foxp3 locus, we next
sought to determine whether this also could be observed in
developing Tregs. Generation of Foxp3
þ cells in the thymus
occurs preferentially at the CD4 SP stage or during transition
to this stage [8]. We therefore isolated CD25
þ and CD25
 
subsets of CD4 SP thymocytes from male mice. As expected,
approximately 80% of CD25
þ CD4 SP thymocytes were
Foxp3
þ, whereas less than 1% of CD25
  CD4 SP thymocytes
expressed Foxp3 (Figure 5A). Only CD25
þ, not CD25
 CD4 SP
thymocytes, displayed demethylated CpG motifs within the
regions covered by amplicons 1 and 2, whereas CpG motifs in
amplicons 3 and 4 were again fully methylated in both subsets
(Figure 5B and Table S1). As expected, in double-negative
(DN) and double-positive (DP) thymocytes, which show hardly
any Foxp3 expression [7,8], CpG motifs within the regions
covered by amplicons 1 and 2 were completely methylated
(Table S1), supporting our assumption that Foxp3 expression
is developmentally regulated and requires an opening of the
foxp3 locus. When compared to peripheral CD25
þCD4
þ Tregs,
in which the CpG motifs within amplicons 1 and 2 were
almost completely demethylated (mean degree of methylation
,3%), CD25
þ CD4 SP thymocytes showed a clearly reduced
degree of demethylated DNA (mean degree of methylation
;50%) with individual CpG motifs being even completely
methylated (Table S1). These stark differences cannot simply
be explained by the fact that, among CD25
þ CD4 SP
thymocytes, only 80% are Foxp3
þ compared to 95% within
the peripheral counterpart (Figures 2B and 5A). Rather, it
indicates that the locus does not become fully opened until
completion of maturation and exit from the thymus.
Weak CpG Demethylation Correlates with Poor Foxp3
Stability in TGF-b–Induced Tregs
A critical issue for application of Tregs in therapeutic
approaches is the availability of large numbers of cells.
Recent publications have reported that conventional
CD25
 CD4
þ T cells can be converted into Foxp3
þ Tregs by
stimulation in the presence of TGF-b [12–17]. However, the
stability and in vivo efﬁcacy of these cells have not been
thoroughly tested so far. Analysis of the accessibility of the
foxp3 locus might provide an additional clue, aside from the
mere expression of Foxp3, as to the extent to which a
permanent conversion into a Treg lineage did occur. We
therefore analyzed the methylation status of the foxp3 locus
from CD25
 CD4
þ T cells, which had been activated and
cultured for 6 d in the presence of TGF-b. On day 6, more
than 98% of TGF-b–cultured cells were Foxp3
þ, whereas
control cells cultured under Th1 conditions showed only
approximately 1% Foxp3 expression (Figure 6A). As ex-
Figure 1. Stable Foxp3 Expression in CD25
þCD4
þ Tregs
CD25
þCD4
þTregs were isolated ex vivo from pooled spleen and LN single-cell suspensions, labeled with CFSE, and then transferred into syngenic 8-wk-
old recipients (2 3 10
6/mouse). Before transfer, sorted cells were analyzed for intracellular Foxp3 expression by FACS. Fourteen days after transfer,
splenocytes of recipient mice were stained for CD4, CD25, and Foxp3, and analyzed by FACS. About 0.1% of total splenocytes and, accordingly, 3% of
total Foxp3
þ splenocytes were donor derived (CFSE
þ). Representative dot and histogram plots from four independently analyzed mice were selected.
Numbers display frequency of cells within indicated populations. Comparable results were obtained for cells isolated from peripheral or mesenteric LNs
(unpublished data). The bars in the left and right graphs indicate the marker gate for Foxp3
þcells. The box in the middle graph indicates the region that
was used to gate for CD4
þCFSE
þ cells. These gated cells (CFSE
þ) are depicted in the right graph.
doi:10.1371/journal.pbio.0050038.g001
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Foxp3 Regulationpected, within cultured Th1 cells, all analyzed CpG motifs
were completely methylated (Figure 6B and Table S1). In
contrast, cell culture in the presence of TGF-b led to a clearly
visible demethylation of CpG motifs within the region
covered by amplicons 1 and 2, whereas CpG motifs in
amplicons 3 and 4 again were fully methylated. However, the
degree of demethylation was far less pronounced compared
to naturally occurring peripheral CD25
þCD4
þ Tregs (Figure
2C). This prompted us to investigate whether such a weak
degree of CpG demethylation might correlate with persistent
expression of Foxp3 in TGF-b–induced Tregs. Therefore, we
restimulated TGF-b–cultured Foxp3
þ cells for another 6 d in
the absence of TGF-b followed by the analysis of intracellular
Foxp3 expression. As a control, we cultured ex vivo isolated
Foxp3
þCD25
þCD4
þ Tregs under comparable conditions.
Whereas ex vivo CD25
þCD4
þ Tregs maintained high Foxp3
levels after cell culture for 6 d, TGF-b–induced Tregs have
lost Foxp3 expression during the 6-d restimulation period to
variable degrees, and initial results point toward an almost
complete loss of the partial demethylation of the CpG motifs
within amplicons 1 and 2 in the restimulated TGF-b cultures
(Figure 7, and unpublished data). To rule out selective
outgrowth of Foxp3
  cells or enhanced cell death of Foxp3
þ
cells during restimulation, we performed TGF-b cultures with
CD25
 CD4
þ T cells from GFP-Foxp3 reporter mice [7], which
allowed sorting of TGF-b–induced Foxp3
þ Tregs to a purity
greater than 99% before restimulation. In other control
experiments, we either labeled TGF-b–induced Tregs with
CFSE before restimulation or did spiking experiments with
Foxp3
  T cells. In none of these control experiments was
outgrowth of Foxp3
  cells or massive cell death observed
(unpublished data), conﬁrming our previous assumption that
Foxp3 expression in TGF-b–induced Tregs is lost during
restimulation in the absence of TGF-b. Importantly, loss of
Foxp3 expression was strictly associated with loss of
suppressive activity when tested in in vitro proliferation
assays (Figure S2). Viewed as a whole, our data strongly
suggest that complete demethylation of CpG motifs within
the foxp3 locus is required to stabilize both Foxp3 expression
and suppressive capacity.
Figure 2. Selectively Demethylated CpG Motifs within the foxp3 Locus in CD25
þCD4
þ Tregs Isolated from Secondary Lymphoid Organs
(A) Schematic view on the foxp3 locus depicts exon-intron structure and position of selected amplicons (Amp 1–4). Shown is the distribution and
position of individual CpG motifs within the amplicons.
(B) CD25
þCD4
þand CD25
 CD4
þT cells were sorted from spleens and LNs pooled from 20 male BALB/c mice. FACS analysis shows the sort purity (upper
panel) and Foxp3 expression in sorted subsets (lower panel). Numbers display frequency of cells within indicated populations. The bars in the lower
graphs indicate the marker gate for Foxp3
þ cells. The vertical and horizontal lines in the upper graphs indicate the quadrant used to identify the
CD4
þCD25
þ/  subsets.
(C) Methylation pattern of selected amplicons of the foxp3 locus in CD25
þCD4
þ Tregs and conventional CD25
 CD4
þ T cells. The amplicons are
subdivided by horizontal lines each representing an individual CpG motif. ESME software [47] is used for normalization and quantification of
methylation signals from sequencing data by calculating ratios of T and C signals at CpG sites. Data are condensed to methylation information at CpG
positions forming matrices of consecutive CpGs. The methylation status of individual CpG motifs within the four amplicons is color coded according to
the degree of methylation at that site. The color code ranges from yellow (0% methylation) to blue (100% methylation) according to the color scale on
the right. CpG motifs from amplicon 2 overlapping with motifs in amplicon 1 were excluded. Due to sequencing problems, the CpG motif 37 from
amplicon 4 is not listed. One representative experiment out of two individual experiments is shown.
doi:10.1371/journal.pbio.0050038.g002
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The forkhead box transcription factor Foxp3 has been
identiﬁed as a speciﬁc molecular marker for Tregs, and its
expression is essential for programming Treg development
and function [2]. Although it is widely accepted that Foxp3
þ
Tregs represent a stable population mainly generated as a
separate lineage in the thymus, conclusive data on the
molecular mechanisms maintaining stable Foxp3 expression
are not available. We here provide evidence that epigenetic
modiﬁcations of the foxp3 locus are required to enable long-
term identity of Foxp3
þ Tregs.
We have identiﬁed an element within the 59 untranslated
region of the foxp3 locus, TSDR (Treg-speciﬁc demethylated
region), which displays demethylated CpG motifs both in
developing thymic as well as in mature, peripheral murine
Foxp3
þCD25
þCD4
þ Tregs. Interestingly, the differentially
methylated element is evolutionarily conserved. Preliminary
analyses using cells from human peripheral blood also
showed a differential methylation of CpG motifs within the
conserved element of the foxp3 locus when conventional
CD25
 CD4
þ T cells and CD25
highCD4
þ Tregs were compared,
implying that this region and its epigenetic regulation is of
functional importance (unpublished data).
In addition to DNA demethylation, acetylated histones H3
and H4 as well as trimethylated histone H3 were associated
with the conserved region in CD25
þCD4
þ Tregs, but not in
conventional CD25
 CD4
þ T cells. Similar histone modiﬁca-
tions have frequently been reported to concur with DNA
demethylation, e.g., as described for the loci encoding the
active cytokines interferon-c (IFN-c) and IL-4 in differ-
entiated Th1 and Th2 cells, respectively [19,20]. These data
suggest that in terminally differentiated Tregs, epigenetic
modiﬁcations of the foxp3 locus allow persistent expression of
Foxp3.
The human FOXP3 promoter has recently been mapped to
the putative 59 end of exon-2b, 6.1 kb upstream from the ﬁrst
coding exon [6]. However, other studies have reported
promoter activity upstream from exon-1 close to the differ-
entially methylated region analyzed in the current study
[26,27] corresponding to the Foxp3 mRNA species AY357712
and AY357713. We could show here by performing luciferase
assays that the differentially methylated region itself possesses
transcriptional activity. Together these data suggest that the
evolutionarily conserved element might belong to an alter-
native TATA-less promoter, which contributes to the
regulation of Foxp3 expression.
The differential methylation status of the foxp3 locus in
Tregs appears to be a new example for epigenetic regulation
of cell lineage differentiation. Although almost all cells in an
individual contain the same complement of DNA code,
higher organisms must impose and maintain different
patterns of gene expression in the various types of differ-
entiated cells. Most gene regulation is transitory, depending
on the current state of the cell and changes in external
stimuli. Persistent regulation, on the other hand, is a primary
role of epigenetics: heritable regulatory patterns that do not
alter the basic genetic coding of the DNA. DNA methylation
is the archetypical form of epigenetic regulation; it serves as
the stable memory for cells and performs a crucial role in
maintaining the long-term identity of various cell types. Our
ﬁnding that evolutionarily conserved sequences within the
Figure 4. Increased Histone Acetylation and K4 Trimethylation in
CD25
þCD4
þ Tregs
ChIP assays were performed with CD25
þCD4
þ Tregs (filled bars) and
conventional CD25
 CD4
þT cells (open bars) sorted from spleens and LNs
pooled from 20 male BALB/c mice. DNA fragments binding to acetylated
or trimethylated histones were immunoprecipitated using antibodies
directed against acetylated histone H3, acetylated histone H4, or
trimethylated histone H3 at position K4. A rabbit isotype immunoglo-
bulin G (IgG) served as control. Precipitated DNA was quantified by real-
time PCR with primers specific for the differentially methylated region of
the foxp3 locus. Sample PCR products were set in relation to input DNA.
One representative experiment out of two individual experiments is
shown.
doi:10.1371/journal.pbio.0050038.g004
Figure 3. Differentially Methylated, Conserved Element of the foxp3
Locus Possesses Transcriptional Activity
RLM-11–1 cells were transfected with control vector (pGL3 promoter) or
Foxp3-CE vector containing the conserved element (CE). Cells were
stimulated with PMA for 24 h. Control cells were left unstimulated.
Results given are relative luciferase light units (RLUs) normalized for
Renilla luciferase activity (mean 6 standard deviation; n¼3). Results are
representative for two independent experiments.
doi:10.1371/journal.pbio.0050038.g003
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Foxp3 Regulationfoxp3 locus are completely and selectively demethylated upon
differentiation into persistent Tregs suggests an important
role of epigenetic ﬁxation for this phenotype.
Moreover, this seems to be the ﬁrst report that a
transcription factor acting as a master switch for a certain
subpopulation is itself subject to epigenetic control. The role
of transcription factors such as T-bet or GATA-3 for the
polarization of Th1 and Th2 cells, respectively, has been
carefully studied, and their interplay with epigenetically
regulated regions in the respective cytokine genes is seen as a
major factor in the acquisition of cytokine memory [18,19].
However, foxp3 appears to be the ﬁrst known example, at least
in the immune system, in which the transcriptional regulation
of a master transcription factor itself involves epigenetic
mechanisms.
A crucial ﬁnding of this study is that chromatin remodeling
of the foxp3 locus does not merely correlate with Foxp3
expression. Rather, our current data provide ﬁrst exper-
imental evidence that the completely demethylated status of
the evolutionarily conserved region is only conﬁned to stable
Treg populations, such as the naturally occurring, thymus-
derived CD25
þCD4
þ cells, and might indeed be a prerequisite
for the permanent commitment to the suppressor cell
lineage. This assumption is based on the analysis of TGF-b–
Figure 6. TGF-b–Induced Tregs Harbor Partially Demethylated CpG Motifs within the foxp3 Locus
(A) CD25
 CD4
þ T cells sorted from spleens and LNs pooled from 20 male BALB/c mice were cultured for 6 d in the presence of TGF-b. Cells cultured
under Th1 conditions were used as control. Within the starting population, less than 1% of the cells were Foxp3
þ(unpublished data). On day 6, cultured
cells were sorted by FACS for CD25
þ cells. FACS analysis shows the purity of sorted subsets (upper panel) and Foxp3 expression in gated CD25
þ cells
derived from indicated cultures (lower panel). Numbers display frequency of cells within indicated populations. The bars in the lower graphs indicate
the marker gate for Foxp3
þcells. The vertical and horizontal lines in the upper graphs indicate the quadrant used to identify the CD4
þCD25
þ/  subsets.
(B) Methylation pattern of selected amplicons of the foxp3 locus in sorted CD25
þ cells derived from indicated cultures. The methylation status of
individual CpG motifs within the four amplicons is color coded as described in Figure 2. One representative experiment out of two individual
experiments is shown. n.a., not analyzed.
doi:10.1371/journal.pbio.0050038.g006
Figure 5. Demethylated CpG Motifs within the foxp3 Locus in CD25
þ CD4 SP Thymocytes
(A) CD25
þCD4
þCD8
  and CD25
 CD4
þCD8
  subsets were sorted from thymocytes pooled from 30 male BALB/c mice. FACS analysis shows purity of
sorted subsets (upper panel) and Foxp3 expression in gated CD25
  and CD25
þ subsets of CD4
þ SP thymocytes (lower panel). Numbers display
frequency of cells within indicated populations. The bars in the lower graphs indicate the marker gate for Foxp3
þcells. The vertical and horizontal lines
in the upper graphs indicate the quadrant used to identify the CD4
þCD25
þ/  subsets.
(B) Methylation pattern of selected amplicons of the foxp3 locus in CD25
þ and CD25
  CD4 SP thymocytes. The methylation status of individual CpG
motifs within the four amplicons is color coded as described in Figure 2. One representative experiment out of two individual experiments is shown.
doi:10.1371/journal.pbio.0050038.g005
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pressive properties, have not acquired a terminally differ-
entiated phenotype and have lost both Foxp3 expression and
suppressive capacity upon restimulation in the absence of
TGF-b. This indicates that the recently postulated positive
autoregulatory loop involving up-regulation of endogenous
TGF-b expression and subsequent Foxp3-dependent down-
regulation of Smad7, a negative regulator of TGF-b signaling,
is not sufﬁcient to induce stable Foxp3 expression in vitro
[15]. As TGF-b–induced Tregs display only weakly demethy-
lated CpG motifs within the conserved region of the foxp3
locus, a more complete CpG demethylation might be the key
for a stable Foxp3 expression, similar to what has recently
been reported for IL-2 [23].
The ﬁndings of this study have important implications with
respect to clinical applications. First, determination of the
methylation status might allow a better identiﬁcation and
quality control of Tregs considered for cellular therapy
concepts of autoimmune diseases, graft-versus-host diseases,
or transplant rejections. Temporary expression of FOXP3
can be detected in activated T cells lacking regulatory
function, especially in the human system [28,29]. Analysis of
the methylation status of the foxp3 locus promises to be a
more reliable marker for the successful conversion of
conventional CD4
þ T cells into a stable population of
suppressor cells.
Second, detection of demethylated foxp3 sequences might
allow the development of novel diagnostic tools for the
quantiﬁcationofTregsinbloodortissues.Bothinautoimmune
diseaseandtumorpatients,acorrelationbetweenTregnumber
and/or activity and disease status has been observed in a
number of recent studies. Decreased activity and/or number of
Tregs has been noted to be associated with myasthenia gravis,
autoimmune polyglandular syndrome type II, ulcerative colitis,
andmultiplesclerosis[30–36].Incontrast,anincreasednumber
of Tregs was observed in patients with a variety of malignant
cancers [37–39], and might be involved in tumor progression
[40–42]. Most notably, presence of Tregs, as deﬁned by gene
expressionofFOXP3,hasbeenshowntoconstituteasigniﬁcant
predictiveparameterfortheclinicaloutcomeinovariancancer
patients [40,41]. However, the analytical value of ﬂow cytom-
etry, immunohistological, and mRNA expression analysis of
CD25 and Foxp3 as accurate diagnostic tools is blurred by both
ambiguity of the markers and instability of the biological
materials. In contrast, our current data show that DNA
demethylation at the foxp3 locus, both in mice and humans,
strictly coincides with the generation of stable Tregs. There-
fore, measurement of the methylation status of the foxp3 locus
could present a more reliable and objective criterion for the
identiﬁcation and quantiﬁcation of Tregs. Moreover, DNA
methylation is intrinsically a more stable parameter than
mRNA expression or protein synthesis, and can be accurately
quantiﬁed [43]. Therefore, we believe that establishment of a
measurement system for the methylation status of the human
foxp3 locus may provide a novel diagnostic tool both in tumor
and in autoimmune disease patients.
Materials and Methods
Mice. BALB/c mice were bred at the BfR (Bundesinstitut fuer
Risikobewertung, Berlin, Germany) and used at 6–12 wk of age. All
animal experiments were performed under speciﬁc pathogen-free
conditions and in accordance with institutional, state, and federal
guidelines.
Antibodies, staining reagents, and cytokines. The following anti-
bodies were produced in our laboratory: anti-FcR II/III (2.4G2), anti-
CD4 (GK1.5), anti-CD3 (145.2C11), anti-CD28 (37.51), and anti–IL-4
(11B11). The following antibodies and secondary reagents were
purchased from BD PharMingen (San Diego, California, United
States): anti-CD4 (RM4–5), anti-CD19 (1D3), anti-CD25 (7D4), anti-
CD8 (53–6.7), anti-CD25 (PC6.1), anti-CD62L (Mel-14), streptavidin,
and appropriate isotype controls. The PE anti-mouse Foxp3 staining
set was purchased from eBioscience (San Diego, California, United
States). All microbeads were obtained from Miltenyi Biotec (Bergisch
Gladbach, Germany) and all cytokines from R & D systems
(Minneapolis, Minnesota, United States).
Flow cytometry. Cytometric analysis was performed as previously
described [44] using a FACS Calibur or a LSRII (BD Biosciences, Palo
Alto, California, United States) and the CellQuest software. Dead cells
were excluded by PI (propidium iodide) or DAPI (diamidopheny-
lindole) staining (Sigma, St. Louis, Missouri, United States). Intra-
cellular Foxp3 staining was performed with the PE anti-mouse Foxp3
staining set according to the manufacturer’s instructions.
Ex vivo cell sorting. CD4
þ T cells were isolated from pooled spleen
and lymph node (LN) single-cell suspensions by using anti–CD4-FITC
plus anti-FITC multisort microbeads and the AutoMACS magnetic
separation system (Miltenyi Biotec). After release of beads according
to the manufacturer’s instructions, CD25
þ and CD25
  cells were
separated using anti–CD25-APC plus anti-APC microbeads. Thymic
single-cell suspensions were sorted for CD8
þ and CD8
  cells using
anti-CD8 microbeads and the AutoMACS magnetic separation
system. MACS-sorted CD8
  thymocytes were subsequently stained
using anti–CD4-FITC, anti–CD25-APC, and anti–CD19-PE, and
sorted into CD25
þ and CD25
  subsets of CD4 SP thymocytes as well
as into CD19
  DN thymocytes by ﬂuorescence-activated cell sorting
(FACS) (FACSAria; BD Bioscience). Magnetic-activated cell sorting
(MACS)-sorted CD8
þ thymocytes were stained using anti–CD4-FITC
Figure 7. TGF-b–Induced Foxp3
þ Tregs Loose Foxp3 Expression upon
Restimulation
(A) CD25
 CD4
þ T cells were cultured for 6 d in the presence of TGF-b as
described in Figure 6. On day 6, cultured cells were sorted by FACS for
CD25
þ cells and analyzed for intracellular Foxp3 expression by FACS
(upper panel). Sorted CD25
þ cells from the same TGF-b-cultures were
restimulated for another 6 d in the absence of TGF-b. On day 6, cultured
cells were analyzed for intracellular Foxp3 expression by FACS (lower
panel). Numbers display frequency of cells within indicated populations.
(B) Ex vivo isolated CD25
þCD4
þ Tregs were analyzed for intracellular
Foxp3 expression before (upper panel) and after 6 d in vitro culture
(lower panel) by FACS. Numbers display frequency of cells within
indicated populations. One representative experiment out of two
individual experiments is shown.
doi:10.1371/journal.pbio.0050038.g007
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Foxp3 Regulationand anti–CD8-PerCP, and sorted into DP thymocytes by FACS. All
subsets were sorted to a purity of greater than 98%.
Adoptive transfer of sorted CD25
þCD4
þT cells. Sorted CD25
þCD4
þ
T cells were labeled with CFSE (Molecular Probes, Eugene, Oregon,
United States) as described before [45]. A total of 2 3 10
6 CFSE-
labeled cells were adoptively transferred into syngenic recipients.
Fourteen days after transfer, single-cell suspensions of spleen,
peripheral, and mesenteric LNs were prepared and stained for
CD4, CD25, and Foxp3 as described above.
TGF-b–induced Tregs. CD4
þ T cells were isolated from pooled
spleen and LN single-cell suspensions by using anti–CD4-FITC plus
anti-FITC multisort microbeads and the AutoMACS magnetic
separation system (Miltenyi Biotec). After release of beads according
to the manufacturer’s instructions, CD25
þcells were depleted by using
anti–CD25-APC plus anti-APC microbeads. To avoid the expansion of
precommitted Foxp3
þ Tregs, we excluded the majority of residual
Foxp3
þ Tregs from the CD25
 CD4
þ T cell fraction by sorting for
CD62L
high cells using anti-CD62L microbeads. MACS-sorted
CD62L
highCD25
 CD4
þ T cells were stimulated for 3 d using plate-
boundanti-CD3(6lg/ml)andanti-CD28(4 lg/ml).ForTh1cultures,5-
lg/ml anti–IL-4, 20-ng/ml IFN-c and 5-ng/ml IL-12 were added to the
medium. For TGF-b cultures, 5-ng/ml TGF-b and 10-ng/ml IL-2 was
used. After 3 d, cells were removed from the stimulus, transferred to
non-coated plates, and cultured for another 3 d. All cell culture was
done with RPMI 1640 (GIBCO, San Diego, California, United States)
supplemented with 10% FCS (Sigma). On day 6, cultured cells were
stained using anti–CD25-APC and sorted for CD25
þ cells by FACS
(FACSAria). Foxp3 expression of sorted CD25
þ cells was analyzed by
intracellular staining. For restimulation experiments, TGF-b–induced
Tregs were sorted for CD25
þ cells by FACS (FACSAria), and sorted
CD25
þcells were stimulated for 3 d using plate-bound anti-CD3 (6 lg/
ml) and anti-CD28 (4 lg/ml) plus IL-2 (10 ng/ml). After 3 d, cells were
removed from the stimulus, transferred to non-coated plates, and
cultured for another 3 d. On day 6, cultured cells were stained for
CD25 and Foxp3 as described above.
Culture of ex vivo isolated CD25
þCD4
þ Tregs. CD25
þ cells were
enriched from pooled spleen and LN single-cell suspensions by using
anti–CD25-FITC, anti-FITC microbeads, and the AutoMACS mag-
netic separation system (Miltenyi Biotec). MACS-enriched CD25
þ T
cells were subsequently stained using anti–CD4-PerCP and anti–
CD62L-APC, and sorted for CD62LhighCD25
þCD4
þ Tregs by FACS
(FACSAria). CD62L
high Tregs were used to avoid the expansion of
Foxp3
 CD25
þ effector T cells. FACS-sorted CD62L
highCD25
þCD4
þ
Tregs were stimulated for 3 d using plate-bound anti-CD3 (6 lg/ml)
and anti-CD28 (4 lg/ml) plus IL-2 (40 ng/ml), followed by transfer to
non-coated plates and culture for another 3 d. On day 6, cultured
cells were stained for CD25 and Foxp3 as described above.
In vitro suppression of naı ¨ve CD4þ T cell proliferation. The assay
was performed as previously described [45]. Proliferation of naı ¨ve
CD62L
highCD25
 CD4
þ responder cells was evaluated according to
CFSE dilution.
Bisulphite sequencing. Genomic DNA was isolated from puriﬁed T
cells using the DNeasy tissue kit (Qiagen, Valencia, California, United
States) following the supplier’s recommendations. Sodium bisulphite
treatment of genomic DNA was performed according to Olek et al.
[46] with minor modiﬁcations, resulting in the deamination of
unmethylated cytosines to uracil, whereas methylated cytosines
remain unchanged. In a subsequent PCR ampliﬁcation, uracils were
replicated as thymidines. Thus, detection of a ‘‘C’’ in sequencing
reactions reﬂects methylation of the genomic DNA at that site.
Detection of a ‘‘T’’ at the same site reﬂects instead the absence of a
methyl modiﬁcation of the genomic cytosine.
PCRs were performed on MJ Research thermocyclers (Waltham,
Massachusetts, United States) in a ﬁnal volume of 25 ll containing 13
PCR Buffer, 1-U Taq DNA polymerase (Qiagen), 200 lM dNTPs, 12.5
pmol each of forward and reverse primers, and 7 ng of bisulphite-
treated genomic DNA. The ampliﬁcation conditions were 95 8C for 15
min and 40 cycles of 95 8C for 1 min, 55 8C for 45 sec, and 72 8C for 1
min, and a ﬁnal extension step of 10 min at 72 8C. PCR products were
puriﬁed using ExoSAP-IT (USB Corp, Staufen, Germany) and
sequenced in both directions applying the PCR primers and the
ABI Big Dye Terminator v1.1 cycle sequencing chemistry (Applied
Biosystems, Foster City, California, United States), followed by
capillary electrophoresis on an ABI 3100 genetic analyzer. Trace ﬁles
were interpreted using ESME, which normalizes sequence traces,
corrects for incomplete bisulphite conversion, and allows for
quantiﬁcation of methylation signals [47]. For each sample, both
PCR ampliﬁcation and sequencing was repeated once. The following
primers (59 to 39 direction) were used for both PCR ampliﬁcation of
bisulphite converted genomic DNA and sequence reactions: Amp 1
(fw: AGGAAGAGAAGGGGGTAGATA; rev: AAACTAACATTC-
CAAAACCAAC), Amp 2 (fw: ATTTGAATTGGATATGGTTTGT;
rev: AACCTTAAACCCCTCTAACATC), Amp 3 (fw: AGAGGTT-
GAAGGAGGAGTATTT; rev: ACTATCTATCCAATTCCCCAAC),
and Amp 4 (fw: TGGTTGTTTTGGAGTTTAGTGT; rev: CACTTTTC-
TACCTTCCACAAAT).
Construction of the luciferase reporter vector. The differentially
methylated, conserved element (CE) of the foxp3 locus was ampliﬁed
by PCR using the mouse BAC RPCIB731D08143Q2 (RZPD) as a
template and the following primers: 59-GATCGGTACCTTGTCC-
CAGGAGAGCGGG-39, and 59-GATCCCCGGGCCCATATGGCTG-
GACCATGG-39.
The ampliﬁed 1,160-bp element was cloned via Asp718 and XmaI
into the pGL3 promoter vector (Promega, Madison, Wisconsin,
United States) in front of the minimal SV40 promoter to generate
pGL3-Foxp3-CE.
Luciferase assay. RLM-11–1 cells [48], which were kindly provided
by Marc Ehlers (Deutsches Rheuma-Forschungszentrum [DRFZ],
Berlin, Germany), or ex vivo isolated CD25þCD4þ Tregs were
transfected using 4 lg of pGL3 promoter vector (control) or pGL3-
Foxp3-CE. Synthetic Renilla luciferase reporter vector (pRL-TK, 0.2
lg; Promega) was used as an internal control for transfection
efﬁciency. Four hours after transfection via nucleofection (Amaxa
Cologne, Germany), RLM-11–1 cells were stimulated with PMA (10 ng/
ml; Sigma) or with PHA (20 ng/ml; Sigma) plus ionomycin (1 lM;
Sigma) in case of ex vivo isolated Tregs. After 18–24-h culture in
IMEM (GIBCO), cells were harvested and luciferase activity was
measured using the dual luciferase assay system (Promega). Data were
normalized to the Renilla luciferase activity.
ChIP. ChIP analysis was carried out according to the manufac-
turer’s protocol (Upstate/Millipore, Billerica, Massachusetts, United
States). Cells (1–5 3 10
6) were ﬁxed with 1% formaldehyde, and
chromatin was fragmented by ultrasound. For all ChIP samples,
sheared chromatin was precleared by incubation with ProteinA-
agarose/salmon sperm DNA (Upstate/Millipore). Subsequently, chro-
matin was immunoprecipitated by overnight incubation at 4 8C with
4-lg antibodies (rabbit isotype, #2027, Santa Cruz Biotechnology
[Santa Cruz, California, United States]; anti–acetyl-histone H3, #06–
599, Upstate/Millipore; anti–acetyl-histone H4, #06–866, Upstate/
Millipore; and anti–trimethyl-K4-histone H3, #07–473, Upstate/
Millipore) followed by incubation with Protein A-agarose/salmon
sperm DNA for 1 h. Precipitates were deﬁxed and DNA was puriﬁed
by using the NucleoSpin Extract II kit (Macherey-Nagel, Du ¨ren,
Germany). The amount of immunoprecipitated DNA was quantiﬁed
by real-time PCR with LightCycler (Roche Applied Science, Basel,
Switzerland) using SYBR Green and the following primer pair (59 to
39 direction): Foxp3 (331 bp) fw: GACTCAAGGGGGTCTCA; rev:
TTGGGCTTCATCGGCAA.
Sample PCR products were set in relation to the input DNA using
the following expression: E
ð½DNAinput  ½DNAIP Þ.
Bioinformatics. Genomic sequences spanning the foxp3 locus were
analyzed using the alignment software vista (http://pipeline.lbl.gov/
servlet/vgb2), allowing the identiﬁcation of conserved regions. Tran-
scription factor binding sites were identiﬁed using the TRANSFAC
database [49] and the search tool MATCH [50].
Supporting Information
Figure S1. CpG Motifs and Transcription Factor Binding Sites within
Differentially Methylated, Conserved Element of the foxp3 Locus
Alignment of mouse (upper row) and human (lower row) genomic
sequences corresponding to amplicons 1 and 2 of the foxp3 locus.
Individual CpG motifs are shown in red, and putative transcription
factor binding site core elements, which were identiﬁed using the
TRANSFAC database and the search tool MATCH, are illustrated as
boxes.
Found at doi:10.1371/journal.pbio.0050038.sg001 (25 KB PDF).
Figure S2. Suppressive Capacity of TGF-b–Induced Tregs
CD25
 CD4
þ T cells were cultured essentially as described in Figure 6.
Cultured cells were incubated with CFSE-labeled naı ¨ve
CD25
 CD62L
high CD4
þ responder T cells at a ratio of 1:1 in the
presence of CD90-depleted APCs and anti-CD3 for 3 d. Proliferation
of naı ¨ve responder cells was evaluated according to CFSE dilution.
Histograms show CFSE staining of responder T cells cultured alone
(positive) or cocultures with ex vivo isolated CD25
þCD4
þ Tregs (ex
vivo), with T cells cultured for 6 d under neutral conditions (neutral),
with T cells cultured for 6 d in the presence of TGF-b (TGF-b), with T
PLoS Biology | www.plosbiology.org February 2007 | Volume 5 | Issue 2 | e38 0176
Foxp3 Regulationcells cultured for 6 d under neutral conditions and restimulated
under neutral conditions (neutral/neutral), and with T cells cultured
for 6 d in the presence of TGF-b followed by restimulation under
neutral conditions (TGF-b/neutral). Representative data from one out
of three independent experiments with similar results are depicted.
Found at doi:10.1371/journal.pbio.0050038.sg002 (72 KB PDF).
Table S1. Methylation Status of Individual CpG Motifs within the
foxp3 Locus
Summary of all DNA methylation analyses performed for indicated
subsets. Shown is the degree of methylation (%) for individual CpG
motifs. CpG motifs from amplicon 2 overlapping with motifs in
amplicon 1 were excluded. n.a., not analyzed.
Found at doi:10.1371/journal.pbio.0050038.st001 (72 KB PDF).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession num-
ber for the forkhead transcription factor Foxp3 is AF277994.
Acknowledgments
We thank Alexander Hellwag, Epiontis GmbH, who performed
bisulphite sequencing.
Author contributions. S .F l o e s s ,A .H a m a n n ,a n dJ .H u e h n
conceived and designed the experiments. S. Floess, J. Freyer, C.
Siewert, U. Baron, J. Polansky, K. Schlawe, H. D. Chang, T. Bopp, and
S. Klein-Hessling performed the experiments. S. Floess, U. Baron, S.
Olek, E. Schmitt, E. Serﬂing, A. Hamann, and J. Huehn analyzed the
data. S. Olek contributed reagents/materials/analysis tools. A. Ha-
mann and J. Huehn wrote the paper.
Funding. This work was supported by the Wilhelm Sander
Foundation, by the German Federal Ministry of Education and
Research (BMBF) (NGFN II, SIPAGE, FKZ 01GS0413), and by the
Deutsche Forschungsgemeinschaft (SFB633 and SFB650).
Competing interests. We herewith state a competing ﬁnancial
interest for the authors S. Olek and U. Baron, who are a founder and
an employee of the company Epiontis, respectively.
References
1. Sakaguchi S (2004) Naturally arising CD4þ regulatory T cells for
immunologic self-tolerance and negative control of immune responses.
Annu Rev Immunol 22: 531–562.
2. Fontenot JD, Rudensky AY (2005) A well adapted regulatory contrivance:
regulatory T cell development and the forkhead family transcription factor
Foxp3. Nat Immunol 6: 331–337.
3. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, et al.
(2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-
linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:
20–21.
4. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the
development and function of CD4þCD25þregulatory T cells. Nat Immunol
4: 330–336.
5. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell
development by the transcription factor Foxp3. Science 299: 1057–1061.
6. Mantel PY, Ouaked N, Ruckert B, Karagiannidis C, Welz R, et al. (2006)
Molecular mechanisms underlying FOXP3 induction in human T cells. J
Immunol 176: 3593–3602.
7. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, et al. (2005)
Regulatory T cell lineage speciﬁcation by the forkhead transcription factor
foxp3. Immunity 22: 329–341.
8. Fontenot JD, Dooley JL, Farr AG, Rudensky AY (2005) Developmental
regulation of Foxp3 expression during ontogeny. J Exp Med 202: 901–906.
9. Thorstenson KM, Khoruts A (2001) Generation of anergic and potentially
immunoregulatory CD25þCD4 T cells in vivo after induction of peripheral
tolerance with intravenous or oral antigen. J Immunol 167: 188–195.
10. Apostolou I, von Boehmer H (2004) In vivo instruction of suppressor
commitment in naive T cells. J Exp Med 199: 1401–1408.
11. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, et al.
(2005) Inducing and expanding regulatory T cell populations by foreign
antigen. Nat Immunol 12: 1219–1227.
12. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. (2003) Conversion of
peripheral CD4þCD25- naive T cells to CD4þCD25þ regulatory T cells by
TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875–
1886.
13. Park HB, Paik DJ, Jang E, Hong S, Youn J (2004) Acquisition of anergic and
suppressive activities in transforming growth factor-beta-costimulated
CD4þCD25- T cells. Int Immunol 16: 1203–1213.
14. Fu S, Zhang N, Yopp AC, Chen D, Mao M, et al. (2004) TGF-beta induces
Foxp3þT-regulatory cells from CD4þCD25 - precursors. Am J Transplant
4: 1614–1627.
15. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, et al. (2004)
Cutting edge: TGF-beta induces a regulatory phenotype in CD4þCD25- T
cells through Foxp3 induction and down-regulation of Smad7. J Immunol
172: 5149–5153.
16. Wan YY, Flavell RA (2005) Identifying Foxp3-expressing suppressor T cells
with a bicistronic reporter. Proc Natl Acad Sci U S A 102: 5126–5131.
17. Fantini MC, Becker C, Tubbe I, Nikolaev A, Lehr HA, et al. (2006) TGF-
fbetag induced Foxp3þ regulatory T cells suppress Th1-mediated
experimental colitis. Gut 55: 671–680.
18. Ansel KM, Lee DU, Rao A (2003) An epigenetic view of helper T cell
differentiation. Nat Immunol 4: 616–623.
19. Reiner SL (2005) Epigenetic control in the immune response. Hum Mol
Genet 14 Spec No 1: R41–R46.
20. Tykocinski LO, Hajkova P, Chang HD, Stamm T, Sozeri O, et al. (2005) A
critical control element for interleukin-4 memory expression in T helper
lymphocytes. J Biol Chem 280: 28177–28185.
21. Sufﬁa IJ, Reckling SK, Piccirillo CA, Goldszmid RS, Belkaid Y (2006)
Infected site-restricted Foxp3þ natural regulatory T cells are speciﬁc for
microbial antigens. J Exp Med 203: 777–788.
22. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, et al. (2001)
Disruption of a new forkhead/winged-helix protein, scurﬁn, results in the
fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27: 68–73.
23. Bruniquel D, Schwartz RH (2003) Selective, stable demethylation of the
interleukin-2 gene enhances transcription by an active process. Nat
Immunol 4: 235–240.
24. Zorn E, Nelson EA, Mohseni M, Porcheray F, Kim H, et al. (2006) IL-2
regulates FOXP3 expression in human CD4þCD25þ regulatory T cells
through a STAT dependent mechanism and induces the expansion of these
cells in vivo. Blood 108: 1571–1579.
25. Dobosy JR, Selker EU (2001) Emerging connections between DNA
methylation and histone acetylation. Cell Mol Life Sci 58: 721–727.
26. Bassuny WM, Ihara K, Sasaki Y, Kuromaru R, Kohno H, et al. (2003) A
functional polymorphism in the promoter/enhancer region of the FOXP3/
Scurﬁn gene associated with type 1 diabetes. Immunogenetics 55: 149–
156.
27. Baratelli F, Lin Y, Zhu L, Yang SC, Heuze-Vourc’h N, et al. (2005)
Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell
function in human CD4þ T cells. J Immunol 175: 1483–1490.
28. Ziegler SF (2006) FOXP3: Of mice and men. Annu Rev Immunol 24: 209–
226.
29. Gavin MA, Torgerson TR, Houston E, Deroos P, Ho WY, et al. (2006)
Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3
expression without regulatory T cell development. Proc Natl Acad Sci U S
A 103.
30. Baecher-Allan C, Haﬂer DA (2004) Suppressor T cells in human diseases. J
Exp Med 200: 273–276.
31. Viglietta V, Baecher-Allan C, Weiner HL, Haﬂer DA (2004) Loss of
functional suppression by CD4þCD25þ regulatory T cells in patients with
multiple sclerosis. J Exp Med 199: 971–979.
32. Kriegel MA, Lohmann T, Gabler C, Blank N, Kalden JR, et al. (2004)
Defective suppressor function of human CD4þCD25þregulatory T cells in
autoimmune polyglandular syndrome type II. J Exp Med 199: 1285–1291.
33. Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, et al. (2005)
Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res 81:
45–52.
34. Offner H, Vandenbark AA (2005) Congruent effects of estrogen and T-cell
receptor peptide therapy on regulatory T cells in EAE and MS. Int Rev
Immunol 24: 447–477.
35. Venken K, Hellings N, Hensen K, Rummens JL, Medaer R, et al. (2006)
Secondary progressive in contrast to relapsing-remitting multiple sclerosis
patients show a normal CD4(þ)CD25(þ) regulatory T-cell function and
FOXP3 expression. J Neurosci Res 83: 1432–1446.
36. Takahashi M, Nakamura K, Honda K, Kitamura Y, Mizutani T, et al. (2006)
An inverse correlation of human peripheral blood regulatory T cell
frequency with the disease activity of ulcerative colitis. Dig Dis Sci 51: 677–
686.
37. Schaefer C, Kim GG, Albers A, Hoermann K, Myers EN, et al. (2005)
Characteristics of CD4þCD25þ regulatory T cells in the peripheral
circulation of patients with head and neck cancer. Br J Cancer 92: 913–920.
38. Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, et al.
(2005) Increased populations of regulatory T cells in peripheral blood of
patients with hepatocellular carcinoma. Cancer Res 65: 2457–2464.
39. Roncador G, Garcia JF, Garcia JF, Maestre L, Lucas E, et al. (2005) FOXP3, a
selective marker for a subset of adult T-cell leukaemia/lymphoma.
Leukemia 19: 2247–2253.
40. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, et al. (2004) Speciﬁc
recruitment of regulatory T cells in ovarian carcinoma fosters immune
privilege and predicts reduced survival. Nat Med 10: 942–949.
41. Wolf D, Wolf AM, Rumpold H, Fiegl H, Zeimet AG, et al. (2005) The
expression of the regulatory T cell-speciﬁc forkhead box transcription
PLoS Biology | www.plosbiology.org February 2007 | Volume 5 | Issue 2 | e38 0177
Foxp3 Regulationfactor FoxP3 is associated with poor prognosis in ovarian cancer. Clin
Cancer Res 11: 8326–8331.
42. Beyer M, Kochanek M, Giese T, Endl E, Weihrauch MR, et al. (2006) In vivo
peripheral expansion of naive CD4þCD25high FOXP3þ regulatory T cells
in patients with multiple myeloma. Blood 107: 3940–3949.
43. Baron U, Tu ¨rbachova I, Hellwag A, Eckhardt F, Berlin K, et al. (2006) DNA
methylation analysis as a tool for cell typing. Epigenetics 1: 55–60.
44. Huehn J, Siegmund K, Lehmann J, Siewert C, Haubold U, et al. (2004)
Developmental stage, phenotype and migration distinguish naive- and
effector/memory-like CD4þ regulatory T cells. J Exp Med 199: 303–313.
45. Siegmund K, Feuerer M, Siewert C, Ghani S, Haubold U, et al. (2005)
Migration matters: Regulatory T cell compartmentalization determines
suppressive activity in vivo. Blood 106: 3097–3104.
46. Olek A, Oswald J, Walter J (1996) A modiﬁed and improved method for
bisulphite based cytosine methylation analysis. Nucleic Acids Res 24: 5064–
5066.
47. Lewin J, Schmitt AO, Adorjan P, Hildmann T, Piepenbrock C (2004)
Quantitative DNA methylation analysis based on four-dye trace data from
direct sequencing of PCR ampliﬁcates. Bioinformatics 20: 3005–3012.
48. Grueter B, Petter M, Egawa T, Laule-Kilian K, Aldrian CJ, et al. (2005)
Runx3 regulates integrin alpha E/CD103 and CD4 expression during
development of CD4-/CD8þ T cells. J Immunol 175: 1694–1705.
49. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, et al. (2006)
TRANFACt and its module TRANSCompelt:T r a n s c r i p t i o n a lg e n e
regulation in eukaryotes. Nucleic Acids Res 34: D108–110.
50. Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, et al.
(2003) MATCH: A tool for searching transcription factor binding sites in
DNA sequences. Nucleic Acids Res 31: 3576–3579.
PLoS Biology | www.plosbiology.org February 2007 | Volume 5 | Issue 2 | e38 0178
Foxp3 Regulation